Therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital are just a few of the trending topics of discussion at the BIO International Convention. LBG Partners …
The record number of gene, gene-modified cell therapies since last year and the recent approval of Gamida Cell’s Omisirge off-the-shelf allogeneic therapy raises an important question: How are other advanced …
Quality oversight, regulatory perspective, and risk management in the changing vendor quality landscape are key topics of discussion at the FDA-NJPQCA Conference on May 23 in Kenilworth, New Jersey. The theme …
Co-authored by Thijs Beuming, Ph.D., “Are Deep Learning Structural Models Sufficiently Accurate for Virtual Screening? Application of Docking Algorithms to AlphaFold2 Predicted Structures” was recently published in the Journal of …
Written by Robert Huebner, Ph.D., “Leveraging modernization of the US influenza vaccine manufacturing base to make better vaccines: a work in progress” was recently published in Vaccine Insights. Dr. Huebner …
The power of science comes to life though innovation and cutting-edge technology at INTERPHEX 2023 in New York City on April 25 – 27. LBG’s Georgia Sloboda, Sri Venkatesan, Frank …
Trending content from every aspect of the pharma supply chain takes front and center at CPHI North America in Philadelphia on April 25 – 27. LBG’s Sayan Paria, who is looking …
The complex contract research market is the focus of BioKansas’ symposium “Access to Research and Infrastructure: The Contract Research Industry.” LBG’s DJ Rezac, Ph.D. and Kyle Kappeler, Ph.D., who have …
LBG’s Tim Alcorn, Ph.D. will join experts from all areas of the global healthcare ecosystem at the HIMSS Global Health Conference & Exhibition in Chicago on April 17 – 21. …
Several LBG team members, including Joshua Speidel, Ph.D. and Robert Huebner, Ph.D., will join vaccine experts to share groundbreaking knowledge and insight at the World Vaccine Congress. The event, …
